The revision of the international sterile manufacturing guideline known as Annex 1 is expected to be released in July, Andrew Hopkins, rapporteur for the revision’s drafting group, announced at the Parenteral Drug Association’s conference on Annex 1 in Berlin, Germany, on June 12.
Hopkins, who is an inspector with the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA), said that revision retains the controversial requirement that manufacturers conduct pre-use post sterilization testing...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?